Building Blocks

Applications 1-(3-ACETYL-2-HYDROXY-5-METHYL-PHENYL)-ETHANONE (cas# 55108-28-6) is a useful research chemical.

Applications Calcium α-Hydroxy-γ-Methylmercaptobutyrate is useful in ion pairing inside Mammals and is therefore useful when it comes to nitrogen retention allowing for animal to grow quickly.
References Opapeju, F., et al.: Animal., 6, 1750-1756 (2012)

Applications Nonpeptide endothelin ETA receptor antagonist. Antihypertensive.
References Riechers, H., et al.: J. Med. Chem., 39, 2123 (1996), Billman, G.E., et al.: Curr. Opin. Invest. Drugs, 3, 1483 (2002), Vatter, H., et al.: Clin. Neuropharmacol., 26, 73 (2003),

Applications A Sulfamethoxazole metabolite.
References Gill, H., et al.: Br. J. Clin. Pharmacol., 42, 347 (1996), Winter, H., et al.: Clin. Pharmacol. Ther., 76, 579 (2004), Vyas, P., et al.: Biochem. Pharmacol., 70, 275 (2005), Vyas, P., et al.: Drug Metab. Dispos., 34, 16 (2006),

Applications 5-Iodouracil is a halogenated pyrimidine that can be used in nucleoprotein photo-crosslinking via RNA substitution. 5-Iodouracil is used in thymidine phosphorylase targeted imaging and therapy. Studies show that DNA N-glycosylase MED1 exhibited higher preference for 5-Iodouracil and halogenated bases over non-halogenated ones.
References Meisenheimer, K. et al.: Meth. Enzymol., 318, 88 (2000); Klecker, R.W. Jr. et al.: Cancer Chemother. Pharmacol., 48, 407 (2001); Turner, D.P. et al.: Cancer Res., 66, 7686 (2006);

Stability Hygroscopic
Applications 3-Amino-3-azabicyclo[3,3,0]octane is used as a reactant in the synthesis of Gliclazide (G409875), a sulfonylurea hypoglycemic agent. Used as an antidiabetic.
References Duhault, J., et al.: Arzneimittel-Forsch., 22, 1686 (1972); Holmes, B., et al.: Drugs, 27, 301 (1984)

Stability Hygroscopic
Applications A synthetic diamidine derivative that acts as a urokinase inhibitor as well as trypsin inhibitor.
References Yamamoto, H. et al.: Aichi Ika Gaig. Igak. Zas., 9, 14 (1981); Geratz, J.D. et al.: Experientia, 25, 1254 (1969); Talhout, R. et al.: Eur. J. Biochem., 268, 1554 (2001);

Applications 4-Aminobenzamide (cas# 2835-68-9) is a useful research chemical.

Applications 4-Amino-2-chloro-3-methylbenzonitrile is a reagent used in synthesis of imidazolin-2-ones, which is designed and synthesized as highly potent, orally active and muscle selective androgen receptor modulators (SARMs).
References Li, J. J., et al.: J. Med. Chem., 50, 3015-3025 (2007)

Applications 1-(4-Amino-3,5-dichlorophenyl)-2-ethanone (cas# 37148-48-4) is a compound useful in organic synthesis.

Applications An intermediate in the production of many biological inhibitors.
References Lambertucci, C., et al.: Bioorg. Med. Chem., 17, 2812 (2009), Lebsack, A., et al.: Bioorg. Med. Chem. Lett., 19, 40 (2009), Griffith, D., et al.: J. Med. Chem., 52, 234 (2009),

Impurity Ipratropium EP Impurity D
Stability Light Sensitive
Applications Atropic acid (Ipratropium EP Impurity D) is an impurity of Ipratropium bromide (I740500) and Atropine Sulfate (A794625).
References Lyon, R., et al.: J. Pharm. Sci., 95, 1549 (2006), Loch, M., et al.: Toxicology, 233, 229 (2007), John, H., et al.: Anal. Bioanal. Chem., 396, 751 (2010),

Applications 1-Octyne was used as a mechanism-based inhibitor of AlkB (nonheme di-iron alkane monooxygenase).
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Alonso, H., et al.: Appl. Environ. Microbio., 78, 7946 (2012)

Applications Befunolol is a β-adrenergic blocker with an intrinsic sympathomimetic action. But it can work as a β-adrenergic partial agonist in isolated organs.
References Nakano, J., et al.: Chem. Pharm. Bull., 36, 1399 (1988); Takayanagi, I., et al.: Gen. Pharmacol., 20, 417 (1989); Koike, K., et al.: Gen. Pharmacol., 25, 1477 (1994)

Applications N-Benzoyl Isothiocyanate (cas# 532-55-8) is a compound useful in organic synthesis.

Applications Antitumor effect potentiator and antitumor agent.
References Chelbova, et al.: Biochem. Pharmacol., 19, 1785 (1970), Collins, J., et al.: Clin. Pharmacol. Ther., 28, 235 (1980), Hoff, P., et al.: Anticancer Drugs, 9, 479 (1998), Backus, H., et al.: Oncol. Res., 12, 231(2000), Peters, G., et al.: J. Clin. Oncol., 19, 4267 (2001).